pharmacopeia

Propionate

US-FDASourced from openFDA
GET
/api/v1/drug/propionate

Indications

Sourced from openFDA
  • Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion itchy, watery eyes itchy nose runny nose sneezing

Dosage & administration

Sourced from openFDA

Directions read the Quick Start Guide for how to: prime the bottle use the spray clean the spray nozzle shake gently before each use use this product only once a day do not use more than directed ADULTS AND CHILDREN 12 YEARS OF AGE AND OLDER Week 1- use 2 sprays in each nostril once daily Week 2 through 6 months- use 1 or 2 sprays in each nostril once daily, as needed to treat your symptoms After 6 months of daily use – ask your doctor if you can keep using CHILDREN 4 TO 11 YEARS OF AGE the growth rate of some children may be slower while using this product. Children should use for the shortest amount of time necessary to achieve symptom relief. Talk to your child’s doctor if your child needs to use the spray for longer than two months a year. an adult should supervise use use 1 spray in each nostril once daily CHILDREN UNDER 4 YEARS OF AGE do not use

Warnings & precautions

Sourced from openFDA

Only for use in the nose. Do not spray into your eyes or mouth.

Approval history

Sourced from openFDA
  • Aug 24, 2000NDANDA021077Glaxo Grp Ltd
  • Sep 29, 2000NDANDA020833Glaxo Grp Ltd
  • Jul 24, 2003NDANDA021535Galderma Labs Lp
  • Feb 5, 2004NDANDA021644Galderma Labs
  • May 14, 2004NDANDA021433Glaxo Grp Ltd
  • Oct 27, 2005NDANDA021835Galderma Labs Lp
  • Jun 8, 2006NDANDA021254Glaxo Grp Ltd
  • May 1, 2012NDANDA202236Mylan Speciality Lp

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
200,494 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Dyspnoea21,84311%
  2. 2Drug Ineffective18,9579.5%
  3. 3Asthma12,6626.3%
  4. 4Cough11,3895.7%
  5. 5Fatigue11,3475.7%
  6. 6Headache10,8585.4%
  7. 7Pneumonia10,0825.0%
  8. 8Nausea9,3594.7%
  9. 9Off Label Use8,9534.5%
  10. 10Pain8,8374.4%
  11. 11Malaise7,9584.0%
  12. 12Diarrhoea7,7593.9%
  13. 13Dizziness7,2513.6%
  14. 14Product Dose Omission Issue6,6283.3%
  15. 15Wheezing6,4533.2%

Literature

View JSON

Recent PubMed references pinned to Propionate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 1,173 ClinicalTrials.gov registrations naming Propionate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

What is Propionate used for?
According to FDA labeling, Propionate carries indications including: Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion itchy, watery eyes itchy nose runny nose sneezing. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for propionate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients